29936-86-5

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
(4-Carbamoylphenoxy)acetic Acid is used as a pharmaceutical agent for its potential choleretic and anti-inflammatory properties, making it a candidate for the development of treatments targeting liver diseases and inflammation.
Used in Chemical Synthesis:
(4-Carbamoylphenoxy)acetic Acid is used as a chemical intermediate in the synthesis of other organic compounds, contributing to the creation of a variety of chemical products.
Used in Agricultural Industry:
(4-Carbamoylphenoxy)acetic Acid is used in the agricultural industry, particularly for its potential applications in herbicide and pesticide formulations, where it can contribute to the development of more effective and targeted crop protection solutions.

InChI:InChI=1/C9H9NO4/c10-9(13)6-1-3-7(4-2-6)14-5-8(11)12/h1-4H,5H2,(H2,10,13)(H,11,12)

Upstream product

• 22042-71-3 (4-formylphenoxy)acetic acid 
• 123-08-0 4-hydroxy-benzaldehyde 

Relevant academic research and scientific papers

IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

A series of substituted 3H imidazo[4,5-b]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES

There are provided according to the invention, novel compounds of formula (I)wherein R, R, R, R, Rand Rare as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.

PEPTIDE DERIVATIVES

The invention concerns pharmaceutically useful trifluoromethyl ketone substituted di-, tri-and tetra-peptide derivatives of the formulae Ia, Ib, Ic set out hereinafter, and salts thereof, which are inhibitors of human leukocyte elastase. Also described herein are pharmaceutical compositions containing a peptide derivative and processes and intermediates for use in the manufacture of the peptide derivatives.